FAB.L Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 liep. 2024 @ 11:29):
Our systems believe the stock currently is undervalued by 0.00% compare to its pairs and should correct upwards.

Stats
Dzisiejszy wolumen	25 225
Średni wolumen	946 307
Kapitalizacja rynkowa	2.96M
EPS	£-0.0292 ( Q2 \| 2023-09-30 )
Następna data zysków	( £0 ) 2024-09-27
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-0.340 (Sector) 0 (Industry) 0
ATR14	£0.0830 (2.68%)

AMYT.L -11.73%

APH.L -0.13%

AVCT.L -0.33%

AZN.L -0.40%

BMK.L 7.59%

BVXP.L -2.16%

C4XD.L 27.32%

CIR.L 0.00%

CLIN.L 0.11%

DEST.L -2.51%

DPH.L 0.05%

EAH.L 3.40%

ERGO.L 0.15%

ETX.L -6.74%

EVG.L 2.25%

FAB.L -1.59%

FARN.L -5.98%

FUM.L 0.27%

GDR.L 1.10%

GNS.L 1.43%

GSK.L -0.48%

HCM.L -0.36%

HEMO.L -2.66%

HIK.L -0.48%

IMM.L -1.15%

INDV.L -0.05%

IXI.L -5.25%

MTPH.L 1 794.74%

MXCT.L -2.17%

N4P.L -4.71%

NCYT.L -2.42%

NFX.L -5.00%

OBD.L 3.33%

OKYO.L -24.32%

ONC.L 0.45%

OPTI.L -3.63%

OVB.L -2.22%

OXB.L 2.87%

PRM.L -4.82%

PRTC.L 0.98%

PYC.L -6.25%

REDX.L 31.58%

RENE.L -2.17%

SAR.L 7.87%

SCLP.L -1.86%

SLN.L -0.93%

SNG.L 3.48%

STX.L 2.70%

TILS.L 8.33%

TRX.L -1.15%

VAL.L 0.00%

VEC.L 0.00%

Korelacja (AI algo v.1.1b): Undervalued: 0.00% £3.10 paired level. (Algorytm śledzi zmiany najbardziej skorelowanych akcji w czasie rzeczywistym i natychmiast aktualizuje)

Fusion Antibodies PLC Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Fusion Antibodies PLC Finanse

Annual	2022
Przychody:	£2.90M
Zysk brutto:	£202 000 (6.96 %)
EPS:	£-0.0998

FY	2022
Przychody:	£2.90M
Zysk brutto:	£202 000 (6.96 %)
EPS:	£-0.0998

FY	2022
Przychody:	£4.80M
Zysk brutto:	£2.47M (51.39 %)
EPS:	£-0.0463

FY	2021
Przychody:	£4.17M
Zysk brutto:	£2.02M (48.60 %)
EPS:	£-0.131

Financial Reports:

No articles found.

Fusion Antibodies PLC Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Fusion Antibodies PLC

Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.